Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1291 of 5804
-
New cocktail of cancer drugs aims to shrink tumors in advanced breast cancer
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.
Phase: PHASE1, PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a sixth day of radiation beat cancer recurrence?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Tailored chemo doses aim to cut severe side effects in digestive cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to establish guidelines for fluoropyrimidine dose reduction according to uracilemia in patients with DPD deficiency in the treatment of digestive cancers. The main question it aims to answer is: \- Which reduction dose of fluoropyrimidine is ne…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Real-World check: does lorlatinib work for ALK lung cancer?
Disease control Recruiting nowAnalysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World context
Phase: NA • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for type 1 diabetes: can common diabetes drugs improve blood sugar control?
Disease control Recruiting nowType 1 Diabetes (T1DM) is a disease characterised by immune mediated destruction of the insulin-producing pancreatic beta cells. Overtime, obvious insulin deficiency develops which requires insulin therapy. T1DM accounts for about 5% to 10% of diabetes cases in Europe and United …
Phase: PHASE2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to predict which blockages need stenting after a heart attack
Knowledge-focused Recruiting nowMost heart attacks occur because a clot forms in a coronary artery blocking blood flow. Without blood heart muscle dies. Untreated, clots can cause a specific type of heart attack -ST-elevation myocardial infarction (STEMI). STEMI patients are treated immediately by finding the b…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could your own fat cells help control diabetes? new study investigates
Disease control Recruiting nowThis prospective clinical study aims to evaluate the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF), enriched with mesenchymal stem cells (ADSCs), for the treatment of Type 2 Diabetes Mellitus (T2DM). Adipose tissue will be harvested using a 12…
Phase: NA • Sponsor: Kaiser Clinic and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a smartphone app stop family violence? new study recruits 1,270 families to find out.
Prevention Recruiting nowThe Family Check-Up Online, a digital health intervention, was designed to improve child mental health through family-centered intervention. The Family Check-Up is grounded in over 25 years of evidence-based research and has been shown to improve child mental health and behavior …
Phase: NA • Sponsor: University of Oregon • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Could a common painkiller boost emergency contraception? new trial tests combo pill
Disease control Recruiting nowThe goal of this clinical trial is to compare the failure rate of the levonorgestrel (LNG)-piroxicam combination regimen versus ulipristal acetate (UPA) as emergency contraception (EC). The main questions it aims to answer are: 1. whether the LNG-piroxicam combination regimen ha…
Phase: PHASE3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Gene-edited cell therapy for beta-thalassemia: long-term safety check begins
Disease control ENROLLING_BY_INVITATIONThis is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-06 (NCT06024876),No investigational drug product will be administered in the study.
Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New BiTE-EV therapy tested for Tough-to-Treat leukemia
Disease control Recruiting nowThe goal of this clinical trial is to learn if BiTE-EV works to treat relapsed/refractory acute B-cell leukemia in adults. It will also learn about the safety of BiTE-EV. The main questions it aims to answer are: Can BiTE-EV effectively treat relapsed/refractory acute B-cell lym…
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control CompletedThis study is open to adults with idiopathic pulmonary fibrosis who are at least 40 years old. The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a lung wash replace needle biopsies for cancer gene tests?
Diagnosis Recruiting nowPatients with advanced non-small cell lung cancer (NSCLC) usually undergo biopsies to obtain cytological material on which to perform Next Generation Sequencing (NGS) analysis, with the aim of identifying driver gene mutations that may be targeted by specific therapies. With the …
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New drug shows promise in keeping blood cancers at bay after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and effectiveness of olutasidenib in preventing the return of disease (relapse) in patients who have undergone donor (allogeneic) hematopoietic cell transplant for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or …
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Real-Time MRI scans during brain surgery could boost tumor removal
Disease control Recruiting nowThe study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical ou…
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug RBS2418 aims to rev up immune system against tough colorectal cancer
Disease control Recruiting nowRBS2418 is a specific immune modulator that works through the inhibition of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and is designed to lead to anti-tumor immunity by protecting endogenous 2'-3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) from…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heat therapy: a new hope for long COVID sufferers?
Symptom relief Recruiting nowPost-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a commo…
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New hope for liver disease: drug shows promise in reducing damage
Disease control OngoingThe purpose of this study is to find out about the safety and how well the study intervention (elafibranor) works in participants with PBC. The participants in this study will have confirmed PBC with inadequate response or intolerance to UDCA, which is a medication used in the ma…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for Hard-to-Treat lymphoma? early trial of ABBV-291 begins
Disease control Recruiting nowNon-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-291 in adult participants in relapse…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Can an app kick the vaping habit? new trial tests digital therapy for teens
Symptom relief Recruiting nowHigh school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they wi…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC